Clinical, pharmacological, and formulation evaluation of disulfiram in the treatment of glioblastoma - a systematic literature review-Reference-Cited by-同舟云学术

Clinical, pharmacological, and formulation evaluation of disulfiram in the treatment of glioblastoma - a systematic literature review

Published:2023-03-21 Issue:4 Volume:20 Page:541-557
ISSN:1742-5247
Container-title:Expert Opinion on Drug Delivery
language:en
Short-container-title:Expert Opinion on Drug Delivery

Author:

Benkő Beáta-Mária¹^ORCID,Lamprou Dimitrios A.²^ORCID,Sebestyén Anna³^ORCID,Zelkó Romána¹^ORCID,Sebe István¹^ORCID

Affiliation:

1. University Pharmacy Department of Pharmacy Administration, Semmelweis University, Budapest, Hungary

2. School of Pharmacy, Queen’s University Belfast, Belfast, UK

3. Tumour Biology, Cell and Tissue Culture Laboratory, 1st Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary

Publisher

Informa UK Limited

Subject

Pharmaceutical Science

Link

https://www.tandfonline.com/doi/pdf/10.1080/17425247.2023.2190581

Reference99 articles.

1. Brain and other central nervous system tumor statistics, 2021

2. Epidemiology and Etiology of Glioblastoma

3. Advances in drug delivery technology for the treatment of glioblastoma multiforme

4. Glioblastoma multiforme: Pathogenesis and treatment

5. Epidemiology of Glioblastoma Multiforme–Literature Review

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cuproptosis and Cu: a new paradigm in cellular death and their role in non-cancerous diseases;Apoptosis;2024-07-16

2. Cyclodextrin encapsulation enabling the anticancer repositioning of disulfiram: Preparation, analytical and in vitro biological characterization of the inclusion complexes;International Journal of Pharmaceutics;2024-05